Blog
Massive Funding Boost for Cultivated Meat Startup
📢 Cultivated meat producer Innocent Meat secures €3m in funding to optimize mass production of stem cell-based meat. 💰🥩🚀🌱
Synthego Corporation spins out its business into a new company, EditCo Bio
📰 Synthego spins off EditCo Bio to deliver edited cells and optimized guide RNA designs for CRISPR therapy. 🔬💼🔀👥
Revolutionary Vaccine Development: Faster Simultaneous Testing
📅 March 26, 2024: Vaccine Development: Multiplexed Solutions on the InDevR VaxArray Platform revolutionizes vaccine development 🧪💉. Faster, more efficient testing of multiple antibodies 🚀🔬. Game-changer in fighting diseases 🌍🔎.
Spanish Company Acquires ALS Treatment for €1225m
🇪🇸 Spanish Ferrer Internacional, SA pays €122.5m for ALS candidate, VRG50635, with promising Phase I trial results. 💰🧪
Novo Nordisk Acquires Cardior Pharmaceuticals for €1025bn Advancing Heart Failure Treatment
📢 Novo Nordisk acquires Cardior Pharmaceuticals for up to €1.025bn! ✨ Exciting Phase II trial for heart failure treatment! ⚙️💡
Stocks of Chinese Biotechs Plummet as Congress Targets National Security
📰 Chinese biotech giants WuXi AppTec and WuXi Biologics face stock plunge as US Congress targets national security. 📉🔒
MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬
Lonza Acquires Genentech’s $12B Biologics Site
📢 Lonza buys Genentech's CA biologics manufacturing site for $1.2B, boosting production capabilities for next-gen therapies. 🏭
Revolutionary Oral Drug Restores Muscle Function
🔬 NDM Pharma & Aarhus University created NMD670, a drug that enhances communication between neurons and muscles in Myasthenia gravis. 🧠💪
Discover the Game-Changing Modulator for Antibodies
🔍 Scientists discovered a new modulator, maduramycin, that enhances M5 glycans in monoclonal antibodies (mAbs). 🧪👩🔬 🔬 Maduramycin offers an alternative to existing modulators for subcutaneously-administered biologics. 💉 🔬 The combination of maduramycin and kifunensine allows control over high-mannose distribution in manufacturing processes. 💪
